FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a thermoreversible, thermoplastic pharmaceutical composition comprising: (a) a biologically active botulinum toxin and (b) a thermoplastic poloxamer wherein poloxamer stabilises botulinum toxin so that botulinum toxin keeps biological activity with botulinum toxin release from the pharmaceutical compositions in vivo, wherein the pharmaceutical composition can be prepared with no substances contained in blood, such as albumin and therefore without any infectious substances of blood components, such as prion.
EFFECT: invention provides high stability and high percentage of the toxin activity recovery.
18 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION BY MODIFIED CLOSTRIDIAL TOXIN | 2010 |
|
RU2568844C2 |
| BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION | 2015 |
|
RU2720991C2 |
| USE OF BOTULINUM NEUROTOXINS IN TREATMENT | 2018 |
|
RU2766147C2 |
| CLOSTRIDIAL NEUROTOXINS WITH MODIFIED PERSISTENCE | 2009 |
|
RU2524429C2 |
| BOTULINUM TOXIN CONTAINING COMPOSITION | 2017 |
|
RU2743746C2 |
| PEPTIDES INHIBITING NEURON EXOCYTOSIS | 2007 |
|
RU2461568C2 |
| COMPOSITIONS AND METHODS FOR IMPROVING DRUG THERAPY WITH METAL ION DEPENDANT AGENTS | 2010 |
|
RU2540520C2 |
| PREPARATIONS OF THERMO-ABRASIVE HYDROGEL FOR APPLICATION IN TREATMENT OF UTERTAL DISORDERS | 2013 |
|
RU2635466C2 |
| LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE | 2017 |
|
RU2741497C2 |
| APOPTOSIS MODULATING COMPOSITIONS WITH CONTROLLED RELEASE AND METHODS OF TREATING EAR DISEASES | 2009 |
|
RU2493828C2 |
